IE 11 is a very old browser and is not supported on this site.

15. Leases

Right-of-use assets

in thousand CHF

Real estate

Vehicles

Total right-of-use assets

Net carrying amount as at 1.1.2020

224,573

361

224,934

Addition

13,751

21

13,772

Reassessment of existing lease contracts

12,397

3

12,400

Depreciation

–48,186

–184

–48,370

Impairment

–2,822

–2,822

Reversal of impairment

86

86

Addition to scope of consolidation

10,276

49

10,325

Net carrying amount as at 31.12.2020

210,074

251

210,325

Addition

27,954

83

28,037

Reassessment of existing lease contracts

20,341

20,341

Depreciation

–49,012

–190

–49,202

Impairment

–22

–22

Addition to scope of consolidation

5,904

117

6,021

Translation differences

–4

–4

Net carrying amount as at 31.12.2021

215,239

257

215,496

Lease liabilities

in thousand CHF

2021

2020

Net carrying amount as at 1 January

218,001

230,568

Addition

28,630

13,772

Reassessment of existing lease contracts

20,341

12,400

Interest expense on lease liabilities

2,298

2,321

Repayment of lease liabilities (including interest)

–52,237

–51,386

Addition to scope of consolidation

6,021

10,325

Translation differences

–4

Net carrying amount as at 31 December

223,051

218,001

– of which current lease liabilities

49,717

47,209

– of which non-current lease liabilities

173,334

170,792

Leases recognised in profit or loss

in thousand CHF

2021

2020

Rental income from operating leases (included in other income)

1,818

2,289

Short-term lease expense (included in other operating costs)

–1,325

–1,460

Low-value lease expense (included in other operating costs)

–36

–19

Variable lease expense (included in other operating costs)

–3,685

–3,590

Depreciation of right-of-use assets

–49,202

–48,370

Impairment of right-of-use assets

–22

–2,822

Reversal of impairment of right-of-use assets

86

Interest expense on lease liabilities

–2,298

–2,321

For one of the leased real estate Galenica acts also as lessor. The related amount is insignificant.

The total cash outflow for leases including short-term leases, leases of low-value-assets and variable lease expenses was CHF 57.3 million (previous year: CHF 56.5 million).

Maturity profile of undiscounted lease liabilities

in thousand CHF

2021

2020

Up to 3 months

13,279

13,009

In 3 to 12 months

38,441

36,261

In 2 years

45,327

42,951

In 3 years

36,024

35,974

In 4 to 5 years

49,171

49,108

In 6 to 10 years

43,103

41,843

In more than 10 years

5,782

7,171

Total future cash flows from undiscounted lease liabilities

231,127

226,317

Possible future cash outflows related to extension options in an amount of CHF 163.2 million (previous year: CHF 124.9 million) are not included in lease liabilities because it is not reasonably certain that these options would be exercised.

The cash outflows for variable lease expenses in 2022 is expected to be similar to the amount recognised in 2021.

Galenica has entered into various lease contracts that have not yet commenced as at 31 December 2021. The future lease payments for these non-cancellable lease contracts amount to CHF 39.6 million (previous year: CHF 16.5 million). This amount includes CHF 27.4 million (previous year: none) for the long-term lease contract of the headquarters beginning in 2027.

Accounting principles leases

A lease is a contract in which the right to use an asset (the underlying asset) is granted for an agreed-upon period in return for consideration. Galenica has lease contracts for vehicles and a large number of contracts for real estate, mainly store locations, which include fixed rental payments and variable sales-based components. The significant majority of these lease contracts concerns locations of the pharmacies in the operating segment Products & Care.

Galenica determines the lease term as the non-cancellable term of the lease, together with any periods covered by an option to extend the lease if it is reasonably certain at inception of the contract to be exercised. Galenica has the option, under some of its leases, to lease the assets for additional terms of several (three, five or more) years. Galenica applies judgement in evaluating whether it is reasonably certain to exercise the option to renew. In doing so, Galenica considers all relevant factors including economic incentives. Galenica reassesses the lease term if there is a significant event or change in circumstances that is within its control and affects its ability to exercise, or not to exercise, the option to renew (e.g. a change in business strategy of the underlying asset).

At the commencement date right-of-use assets are capitalised at a value equivalent to the lease liability, plus initial direct costs and lease payments made before the commencement date, less any lease incentives received.

Galenica uses the recognition exemptions for lease contracts that have a lease term of 12 months or less and do not contain a purchase option (short-term leases), and lease contracts for which the underlying asset is of low value (low-value assets).

The lease liability represents the net present value of fixed or in substance fixed lease payments over the lease term. Lease liabilities are discounted using the incremental borrowing rate if the rate implicit in the lease is not readily determinable. Non-lease components are not included in the lease liabilities and are accounted for in accordance with applicable standards. The interest charge is presented as interest expense on lease liabilities.

Right-of-use assets are depreciated over the shorter of the useful life of the right-of-use asset or the lease term.

Right-of-use assets are tested for impairment whenever there are indications that they could be impaired. Any impairment is recognised in profit or loss under depreciation and amortisation and disclosed separately as an impairment. Reversal of impairments on right-of-use assets are recognised immediately in profit or loss.

Galenica uses cookies to optimise the functions of the website and to ensure you enjoy the best possible experience. Use of cookies & disclaimer